a Provided by: National Resource Center on Domestic Violence, PreventConnect, and the Center for Disease Control Web Conference
Date: Friday, September 14, 2018
Time: 4:00 am – 5:00 am ChST
New Report and Web Conference on the Costs to Society from Intimate Partner Violence (IPV)
The costs from intimate partner violence (IPV) are substantial, according to a report from the Centers for Disease Control and Prevention (CDC) in the American Journal of Preventive Medicine (AJPM). The study used nationally-representative data from CDC’s 2012 National Intimate Partner and Sexual Violence Survey (NISVS) to estimate the economic costs to society over the lifetime of all people who report experiencing IPV at some point in their lives.
PreventConnect Web Conference
Please join PreventConnect, the National Resource Center on Domestic Violence, and CDC researchers to learn more about the long-term economic cost of intimate partner violence and implications for prevention policy and practice, September 13, 2018 at 2 pm Eastern.
Register for The Economic Cost of Intimate Partner Violence: Implications for Prevention.
Key Findings
- The lifetime per-victim cost was $103,767 for women and $23,414 for men. This reflected differences in outcomes (e.g., rape-related pregnancy), differences in the number of affected victims by sex for particular outcomes, as well as a lack of studies on this topic that include male victims.
- The lifetime per-victim cost is for adults who report experiencing IPV at some point in their lives. This includes almost 32 million women and 12 million men who are victims of IPV during their lives.
- This cost includes things like medical costs, lost work productivity, and criminal justice costs.
Prevention
- Preventing IPV is a priority for CDC’s National Center for Injury Prevention and Control.
- IPV is not inevitable. It is a public health problem that can be prevented.
- CDC places an emphasis on primary prevention—stopping violence before it begins.
- CDC has a technical package to help states and communities take advantage of the best available evidence to prevent IPV.